Intensive chemotherapy for solid tumours—Current clinical applications Stanley B. Kaye Review Pages: 127 - 133
A new nitrosourea derivative TA-077, 1-(2-Chloroethyl)-3-isobutyl-3-(β-maltosyl)-1-nitrosourea S. FujimotoM. Ogawa Original Articles Pages: 134 - 139
Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II A. H. CalvertS. J. HarlandK. R. Harrap Original Articles Pages: 140 - 147
Role of the host in the variable chemotherapeutic response of advanced Ridgway osteogenic sarcoma J. Arly NelsonJames A. HokansonVernon K. Jenkins Original Articles Pages: 148 - 155
High-dose methotrexate: A clinical and pharmacokinetic evaluation R. FavreS. MonjanelY. Carcassonne Original Articles Pages: 156 - 160
Effects of polysorbate 80 on the absorption and distribution of oral methotrexate (MTX) in mice M. Noor AzminJames F. B. StuartAlexander T. Florence Original Articles Pages: 161 - 164
Effect of combination chemotherapy, duration of methotrexate administration, and Patient's age on methotrexate pharmacokinetics François LokiecOdette PoirierYves Najean Original Articles Pages: 165 - 168
Clinical pharmacology of bruceantin by radioimmunoassay K. L. L. FongD. H. W. HoG. P. Bodey Original Articles Pages: 169 - 172
Nonlinear pharmacokinetics for the elimination of 5-fluorouracil after intravenous administration in cancer patients B. J. McDermottH. W. van den BergR. F. Murphy Original Articles Pages: 173 - 178
Prophylaxis against hypomagnesaemia induced by cis-platinum combination chemotherapy V. M. MacaulayR. H. J. BegentE. S. Newlands Short Communication Pages: 179 - 181